Multiple drugsQTc interval prolongation following off-label use: 5 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1908卷 / 1期

关键词：

D O I：

10.1007/s40278-022-16136-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：408 / 408

相关论文

共 50 条

[31] IvabradineTorsades de pointes and QTc interval prolongation following off-label use: case report
Reactions Weekly, 2023, 1957 (1) : 323 - 323
[32] Haloperidol/quetiapineQTc prolongation and dystonic reaction following off-label use: 2 case reports
Reactions Weekly, 2021, 1865 (1) : 204 - 204
[33] Antivirals/fluoroquinolonesProlongation of QTc interval following off-label use: 9 case reports
Reactions Weekly, 2021, 1855 (1) : 60 - 60
[34] Multiple drugsQTc prolongation: 4 case reports
Reactions Weekly, 2017, 1637 (1) : 155 - 155
[35] Multiple drugsLack of efficacy following off-label use: 3 case reports
Reactions Weekly, 2022, 1897 (1) : 251 - 251
[36] Multiple drugsLack of efficacy following off-label use: 4 case reports
Reactions Weekly, 2022, 1929 (1) : 448 - 448
[37] Multiple drugsQTc prolongation: 3 case reports
Reactions Weekly, 2016, 1600 (1) : 155 - 155
[38] Multiple drugsQTc prolongation : 6 case reports
Reactions Weekly, 2024, 2017 (1) : 381 - 381
[39] Multiple drugsLack of efficacy following off-label use: 6 case reports
Reactions Weekly, 2022, 1930 (1) : 386 - 386
[40] Multiple drugsLack of efficacy following off-label use: 2 case reports
Reactions Weekly, 2022, 1907 (1) : 333 - 333

← 1 2 3 4 5 →